J Carlo Hojilla
Overview
Explore the profile of J Carlo Hojilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
402
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wohl D, Spinner C, Flamm J, Hare C, Doblecki-Lewis S, Ruane P, et al.
Lancet HIV
. 2024 Jul;
11(8):e508-e521.
PMID: 39008999
Background: Data characterising the long-term use and safety of emtricitabine plus tenofovir disoproxil fumarate as daily oral pre-exposure prophylaxis (PrEP) are scarce and there are uncertainties regarding the value of...
2.
Nation A, Pelayo J, Trevino M, Ambalada A, Hojilla J, Raynor P, et al.
Nurs Adm Q
. 2023 Dec;
48(1):11-20.
PMID: 38049096
There are approximately 90 000 lesbian, gay, bisexual, and transgender (LGBT) individuals in Orange County, California. LGBT individuals have significant health disparities, particularly if they are from racial or ethnic...
3.
Tang A, Hojilla J, Jackson J, Rothenberg K, Gologorsky R, Stram D, et al.
Ann Plast Surg
. 2022 Oct;
88(4 Suppl):S325-S331.
PMID: 36248210
Background: There are over 150,000 transgender adolescents in the United States, yet research on outcomes following gender-affirming mastectomy in this age group is limited. We evaluated gender-affirming mastectomy incidence, as...
4.
Hojilla J, Sarovar V, Lam J, Park I, Vincent W, Hare C, et al.
AIDS Behav
. 2022 Aug;
27(1):96-105.
PMID: 35916949
Annual screening for bacterial sexually transmitted infections (STI), including gonorrhea/chlamydia (GC/CT) and syphilis, is recommended for persons with HIV (PWH). We used the prevention index to quantify the extent to...
5.
Satre D, Sarovar V, Leyden W, Leibowitz A, Lam J, Hojilla J, et al.
Aging Ment Health
. 2022 Jun;
27(5):1011-1019.
PMID: 35765902
People living with HIV (PWH) have seen reduction in HIV-associated morbidity and increase in near-normal life expectancy, yet unhealthy alcohol use poses substantial risks to older as well as younger...
6.
Saberi P, Stoner M, Ming K, Lisha N, Hojilla J, Scott H, et al.
AIDS
. 2022 Jun;
36(13):1783-1789.
PMID: 35730363
Objective: The HIV preexposure prophylaxis optimization intervention (PrEP-OI) study evaluated the efficacy of a panel management intervention using PrEP coordinators and a web-based panel management tool to support healthcare providers...
7.
Cespedes M, Das M, Hojilla J, Blumenthal J, Mounzer K, Ramgopal M, et al.
PLoS One
. 2022 Jun;
17(6):e0267780.
PMID: 35657826
Introduction: Black and Hispanic/Latinx cisgender men who have sex with men (MSM), transgender women, transgender men, and gender nonbinary (TGNB) individuals have been historically underrepresented in HIV pre-exposure prophylaxis (PrEP)...
8.
Hojilla J, Gandhi M, Satre D, Johnson M, Saberi P
Lancet HIV
. 2022 Feb;
9(3):e145-e147.
PMID: 35131041
No abstract available.
9.
Hojilla J, Hurley L, Marcus J, Satre D, Silverberg M, Zaritsky E, et al.
J Acquir Immune Defic Syndr
. 2021 Nov;
89(3):e30.
PMID: 34723924
No abstract available.
10.
Hojilla J, Hurley L, Marcus J, Silverberg M, Skarbinski J, Satre D, et al.
JAMA Netw Open
. 2021 Aug;
4(8):e2122692.
PMID: 34436609
Importance: Long-term follow-up is needed to evaluate gaps in HIV preexposure prophylaxis (PrEP) care delivery and to identify individuals at risk for falling out of care. Objective: To characterize the...